Woodland Hills, CA – February 25, 2025– The Terasaki Institute's recent media contest, "Beyond the Horizon: The Future of Bioengineering," drew outstanding entries from across our community, exploring the intersection of art and science. Participants captured scientific phenomena through photography and videography, showcasing everything from intricate patterns in nature to groundbreaking laboratory experiments.
Los Angeles, CA – February 12, 2025—Researchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin (E-Skin) that repairs itself in seconds after damage. This could potentially transform the landscape of personal health monitoring.
Los Angeles, CA – February 6, 2025 - The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Liangfang Zhang - Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California San Diego, and Dr. Aydogan Ozcan – Chancellor’s Professor, UCLA & Professor, Howard Hughes Medical Institute (HHMI), as the recipients of the inaugural Keith Terasaki Mid-Career Innovation Award. These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.
Los Angeles, CA – February 5th, 2025 - The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Cato Laurencin, Chief Executive Officer, Connecticut Convergence Institute, Professor, University of Connecticut as the recipient of the 2025 Paul Terasaki Innovation Award and Dr Jun Chen, Associate Professor, Department of Bioengineering, University of California, Los Angeles (UCLA), as the recipient of the 2025 Hisako Terasaki Young Innovator Award. These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.
Los Angeles, CA – January 27, 2025 - Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a new study published in Advanced Functional Materials. The breakthrough centers on a new class of materials called lipopeptide hydrogels (LPHs), which show promise in boosting immune responses and possess adjuvant-like properties.
Los Angeles, CA – January 24, 2025 - The Terasaki Institute for Biomedical Innovation- in Los Angeles and the Technology Innovation Institute (TII), the dedicated research arm of Abu Dhabi’s Advanced Technology Research Council (ATRC), have started a new collaboration to advance drug discovery and disease modeling related to neurological conditions.
(LOS ANGELES) — It is with a heavy heart that the Terasaki Institute announces the passing of our beloved Chairman of the Board, Dr. Keith Terasaki. Dr. Keith passed away peacefully on the morning of Sunday, December 22, 2024, after a courageous battle with a rare form of lymphoma. His loss is deeply felt by all who had the privilege of knowing him.
(LOS ANGELES) — The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to welcome five new members to its Leadership Board. The TIBI Leadership Board comprises notable visionary individuals who utilize their expertise to promote key initiatives and provide valuable guidance on the institute's research and innovation strategies.